Insulin glargine versus other types of basal insulin–clinical and tumor characteristics in patients with breast carcinoma

BACKGROUND: Recent epidemiological studies have suggested that some insulin analogues could be associated with an increased risk of cancer. The aim of this retrospective study was to examine whether patients with diabetes mellitus (DM) using insulin glargine have a higher tumor stage of breast carci...

Descripción completa

Detalles Bibliográficos
Autores principales: Besic, Nikola, Satej, Nika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852785/
https://www.ncbi.nlm.nih.gov/pubmed/24131755
http://dx.doi.org/10.1186/1756-0500-6-416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852785/
https://www.ncbi.nlm.nih.gov/pubmed/24131755
http://dx.doi.org/10.1186/1756-0500-6-416

Ejemplares similares